Home Latest Bharat biotech to enroll 375 people in the first phase and 750 in the second phase of clinical trials: ICMR

Bharat biotech to enroll 375 people in the first phase and 750 in the second phase of clinical trials: ICMR

by the owl speaks

The ICMR is all geared towards strengthening the process of developing a novel coronavirus vaccine, as India is the top third country in terms of the number of coronavirus cases. ICMR mentioned that Bharat Biotech is planning to enroll 375 people in the first phase of clinical trials and 750 in the second phase. The ICMR also stated that its process is precisely in accordance with the globally acceptable norms.

You may also like

Leave a Comment

so